Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance.
Dahn ML, Cruickshank BM, Jackson AJ, Dean C, Holloway RW, Hall SR, Coyle KM, Maillet H, Waisman DM, Goralski KB, Giacomantonio CA, Weaver ICG, Marcato P.
Dahn ML, et al. Among authors: waisman dm.
Mol Cancer Ther. 2020 May;19(5):1110-1122. doi: 10.1158/1535-7163.MCT-19-0745. Epub 2020 Mar 10.
Mol Cancer Ther. 2020.
PMID: 32156786